Neurological toxicities associated with chimeric antigen receptor T-cell therapy-Reference-Cited by-同舟云学术

Neurological toxicities associated with chimeric antigen receptor T-cell therapy

Published:2019-03-19 Issue:5 Volume:142 Page:1334-1348
ISSN:0006-8950
Container-title:Brain
language:en
Short-container-title:

Author:

Rubin Daniel B¹²,Danish Husain H¹²,Ali Ali Basil¹,Li Karen¹,LaRose Sarah¹,Monk Andrew D¹,Cote David J³,Spendley Lauren⁴,Kim Angela H¹,Robertson Matthew S⁵,Torre Matthew⁶,Smith Timothy R⁷,Izzy Saef¹,Jacobson Caron A⁴,Lee Jong Woo¹,Vaitkevicius Henrikas¹

Affiliation:

1. Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA

2. Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA

3. Department of Neurosurgery; Channing Division of Network Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA

4. Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA

5. Division of Nuclear Medicine, Department of Radiology, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA

6. Department of Pathology, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA

7. Department of Neurosurgery, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA

Funder

American Clinical Neurophysiology Society

Critical Care EEG Monitoring Research Consortium

Publisher

Oxford University Press (OUP)

Subject

Neurology (clinical)

Link

http://academic.oup.com/brain/article-pdf/142/5/1334/28769086/awz053.pdf

Reference33 articles.

1. Chimeric antigen receptor T-cell therapies for lymphoma;Brudno;Nat Rev Clin Oncol,2018

2. Measuring IL-6 and sIL-6R in serum from patients treated with tocilizumab and/or siltuximab following CAR T cell therapy;Chen;J Immunol Methods,2016

3. Which EEG patterns warrant treatment in the critically ill? Reviewing the evidence for treatment of periodic epileptiform discharges and related patterns;Chong;J Clin Neurophysiol,2005

4. Efficacy and toxicity management of 19–28z CAR T cell therapy in B cell acute lymphoblastic leukemia;Davila;Sci Transl Med,2014

5. Cerebrovascular disorders complicating pregnancy;Feske;Continuum (Minneap Minn),2014

Cited by 176 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. FDG-PET/CT Imaging in Chimeric Antigen Receptor–Engineered T-Cell Treatment in Patients with B-Cell Lymphoma;PET Clinics;2024-10

2. EEG before chimeric antigen receptor T-cell therapy and early after onset of immune effector cell-associated neurotoxicity syndrome;Clinical Neurophysiology;2024-07

3. CAR-T Cell Therapy and the Neurointensivist;Neurocritical Care;2024-05-28

4. Impact of diagnostic investigations in the management of CAR T-cell–associated neurotoxicity;Blood Advances;2024-05-21

5. An Assessment of the Effectiveness and Safety of Chimeric Antigen Receptor T-Cell Therapy in Multiple Myeloma Patients with Relapsed or Refractory Disease: A Systematic Review and Meta-Analysis;International Journal of Molecular Sciences;2024-05-03